{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:09:50Z","timestamp":1767823790773,"version":"3.49.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1097\/01.mph.0000212950.12856.d4","type":"journal-article","created":{"date-parts":[[2006,7,5]],"date-time":"2006-07-05T07:11:41Z","timestamp":1152083501000},"page":"446-449","source":"Crossref","is-referenced-by-count":17,"title":["Mast Cell Disease"],"prefix":"10.1097","volume":"28","author":[{"given":"Sharat","family":"Damodar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin Noel","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayathri","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devi Prasad","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210227","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0145-2126(01)00030-3","article-title":"Mast cell lineage development and phenotypic regulation","volume":"25","author":"Austen","year":"2001","journal-title":"Leuk Res"},{"key":"R2-8-20210227","first-page":"83","article-title":"Targeted Therapy in Rheumatology","volume":"1","author":"Valent","year":"2003"},{"key":"R3-8-20210227","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings","volume":"25","author":"Horny","year":"2001","journal-title":"Leuk Res"},{"key":"R5-8-20210227","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0889-8588(05)70298-7","article-title":"Gastrointestinal abnormalities and involvement in systemic mastocytosis","volume":"14","author":"Jensen","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"R6-8-20210227","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1111\/1523-1747.ep12469022","article-title":"The liver, spleen, and lymph nodes in mastocytosis","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"R7-8-20210227","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"R9-8-20210227","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM200101253440415","article-title":"Treatment of systemic mast-cell disease with cladribine","volume":"344","author":"Tefferi","year":"2001","journal-title":"N Engl J Med"},{"key":"R10-8-20210227","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"key":"R11-8-20210227","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"R12-8-20210227","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-Kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"R13-8-20210227","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1398-9995.2005.00592.x","article-title":"Systemic mastocytosis associated with recurrent paroxysmal atrial fibrillation","volume":"60","author":"Ricciardi","year":"2005","journal-title":"Allergy"},{"key":"R14-8-20210227","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1365-2044.1998.00536.x","article-title":"Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia","volume":"53","author":"Vaughan","year":"1998","journal-title":"Anaesthesia"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000658-200604000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T04:55:06Z","timestamp":1618030506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-200607000-00008"}},"subtitle":["Surgical and Anesthetic Implications"],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mph.0000212950.12856.d4","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}